Panagora Asset Management’s Clearside Biomedical CLSD Stock Holding History

Panagora Asset Management’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-166	Closed	-$4K	–	2824
2020 Q3	$4K	Buy	+166	New	+$4.29K	﹤0.01%	2483
2019 Q2	–	Sell	-4,260	Closed	-$88K	–	2617
2019 Q1	$88K	Hold	4,260	–	–	﹤0.01%	1913
2018 Q4	$68K	Buy	+4,260	New	+$200K	﹤0.01%	1897
2017 Q3	–	Sell	-69	Closed	-$9K	–	2344
2017 Q2	$9K	Buy	+69	New	+$8.29K	﹤0.01%	2472

Other funds holding CLSD

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

AIIC

AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Panagora Asset Management's CLSD Position: Q4 2020 in Review

Panagora Asset Management sold out of Clearside Biomedical (CLSD) in Q4 2020, closing a stake of 166 shares — an estimated $4K sold.

Panagora Asset Management first reported a position in CLSD in Q2 2017 and held it in 4 quarters. The position peaked at $88K in Q1 2019. 42 funds tracked by Wall St. Rank hold CLSD as of Q4 2020.

Panagora Asset Management reported no remaining Clearside Biomedical position as of Q4 2020 after selling out during the quarter.
Panagora Asset Management sold 166 Clearside Biomedical shares in Q4 2020, an estimated $4K.
Panagora Asset Management first reported a position in Clearside Biomedical in Q2 2017 and held it in 4 quarters.
Panagora Asset Management's Clearside Biomedical position peaked at $88K in Q1 2019.
42 funds tracked by Wall St. Rank held Clearside Biomedical as of Q4 2020.

Based on Panagora Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.